Primary cutaneous follicle centre lymphoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T1a | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T1a | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | A solitary lesion <5 cm diameter | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T1 b | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T1 b | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | A solitary >5 cm diameter | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #D3D3D3;" | T2 | | style="text-align: center; padding: 5px 5px; background: #D3D3D3;" | T2 | ||
| style="padding: 5px 5px; background: #D3D3D3;" | Regional skin involvement: multiple lesions limited to 1 body region or 2 contiguous body regions | | style="padding: 5px 5px; background: #D3D3D3;" | Regional skin involvement: multiple lesions limited to 1 body region or 2 contiguous body regions | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T2a | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T2a | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | All-disease-encompassing in a <15-cm-diameter circular area | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T2 b | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T2 b | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | All-disease-encompassing in a >15- and <30-cm-diameter circular area | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T2 b | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T2 b | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | All-disease-encompassing in a >30-cm-diameter circular area | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #D3D3D3;" | T3 | | style="text-align: center; padding: 5px 5px; background: #D3D3D3;" | T3 | ||
Line 38: | Line 38: | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T3a | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T3a | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | Multiple lesions involving 2 noncontiguous body regions | ||
|- | |- | ||
| style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T3b | | style="text-align: center; padding: 5px 5px; background: #F5F5F5;" | T3b | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | Multiple lesions involving ≥3 body regions | ||
|- | |- | ||
! style="background: #A9A9A9;" rowspan="5"| N | ! style="background: #A9A9A9;" rowspan="5"| N |
Revision as of 21:08, 1 March 2016
Primary cutaneous follicle centre lymphoma Microchapters |
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary cutaneous follicle centre lymphoma staging On the Web |
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma staging |
Primary cutaneous follicle centre lymphoma staging in the news |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Risk calculators and risk factors for Primary cutaneous follicle centre lymphoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Staging
Name | Stage | Description |
---|---|---|
T | ||
T1 | Solitary skin involvement | |
T1a | A solitary lesion <5 cm diameter | |
T1 b | A solitary >5 cm diameter | |
T2 | Regional skin involvement: multiple lesions limited to 1 body region or 2 contiguous body regions | |
T2a | All-disease-encompassing in a <15-cm-diameter circular area | |
T2 b | All-disease-encompassing in a >15- and <30-cm-diameter circular area | |
T2 b | All-disease-encompassing in a >30-cm-diameter circular area | |
T3 | Generalized skin involvement | |
T3a | Multiple lesions involving 2 noncontiguous body regions | |
T3b | Multiple lesions involving ≥3 body regions | |
N | ||
N0 | No clinical or pathologic lymph node involvement | |
N1 | Involvement of 1 peripheral lymph node region that drains an area of current or prior skin involvement | |
N2 | Involvement of 2 or more peripheral lymph node regions or involvement of any lymph node region† that does not drain an area of current or prior skin involvement | |
N3 | Involvement of central lymph nodes | |
M | ||
M0 | No evidence of extracutaneous non–lymph node disease | |
M1 | Extracutaneous non–lymph node disease present |